143 related articles for article (PubMed ID: 9398911)
1. Natural and experimental Helicobacter mustelae reinfection following successful antimicrobial eradication in ferrets.
Batchelder M; Fox JG; Hayward A; Yan L; Shames B; Murphy JC; Palley L
Helicobacter; 1996 Mar; 1(1):34-42. PubMed ID: 9398911
[TBL] [Abstract][Full Text] [Related]
2. Characterization and therapy for experimental infection by Helicobacter mustelae in ferrets.
Czinn SJ; Bierman JC; Diters RW; Blanchard TG; Leunk RD
Helicobacter; 1996 Mar; 1(1):43-51. PubMed ID: 9398912
[TBL] [Abstract][Full Text] [Related]
3. Ranitidine bismuth citrate and clarithromycin, alone or in combination, for eradication of Helicobacter mustelae infection in ferrets.
Marini RP; Fox JG; Taylor NS; Yan L; McColm AA; Williamson R
Am J Vet Res; 1999 Oct; 60(10):1280-6. PubMed ID: 10791942
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence in situ hybridization confirms clearance of visible Helicobacter spp. associated with gastritis in dogs and cats.
Jergens AE; Pressel M; Crandell J; Morrison JA; Sorden SD; Haynes J; Craven M; Baumgart M; Simpson KW
J Vet Intern Med; 2009; 23(1):16-23. PubMed ID: 19175715
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Helicobacter pylori infection: a review of the world literature.
van der Hulst RW; Keller JJ; Rauws EA; Tytgat GN
Helicobacter; 1996 Mar; 1(1):6-19. PubMed ID: 9398908
[TBL] [Abstract][Full Text] [Related]
7. The effect of intragastric acidity on Helicobacter pylori eradication with bismuth-metronidazole-amoxicillin.
Chang CS; Yang CY; Wong FN; Chen GH; Lien HC; Yeh HZ; Poon SK
Hepatogastroenterology; 1999; 46(28):2713-7. PubMed ID: 10522070
[TBL] [Abstract][Full Text] [Related]
8. Relevance of the ferret model of Helicobacter-induced gastritis to evaluation of antibacterial therapies.
Alder JD; Ewing PJ; Mitten MJ; Oleksijew A; Tanaka SK
Am J Gastroenterol; 1996 Nov; 91(11):2347-54. PubMed ID: 8931416
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen.
Kahramanoğlu Aksoy E; Pirinçci Sapmaz F; Göktaş Z; Uzman M; Nazlıgül Y
Med Princ Pract; 2017; 26(6):523-529. PubMed ID: 29131124
[TBL] [Abstract][Full Text] [Related]
10. Eradication of Helicobacter mustelae from the ferret stomach: an animal model of Helicobacter (Campylobacter) pylori chemotherapy.
Otto G; Fox JG; Wu PY; Taylor NS
Antimicrob Agents Chemother; 1990 Jun; 34(6):1232-6. PubMed ID: 2393285
[TBL] [Abstract][Full Text] [Related]
11. Treatment of gastritis in cheetahs (Acinonyx jubatus).
Wack RF; Eaton KA; Kramer LW
J Zoo Wildl Med; 1997 Sep; 28(3):260-6. PubMed ID: 9365937
[TBL] [Abstract][Full Text] [Related]
12. Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.
Srinarong C; Siramolpiwat S; Wongcha-um A; Mahachai V; Vilaichone RK
Asian Pac J Cancer Prev; 2014; 15(22):9909-13. PubMed ID: 25520127
[TBL] [Abstract][Full Text] [Related]
13. Effect of triple therapy on eradication of canine gastric helicobacters and gastric disease.
Happonen I; Linden J; Westermarck E
J Small Anim Pract; 2000 Jan; 41(1):1-6. PubMed ID: 10713975
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing the eradication of Helicobacter pylori with triple therapy.
Graham DY; Lew GM; Malaty HM; Evans DG; Evans DJ; Klein PD; Alpert LC; Genta RM
Gastroenterology; 1992 Feb; 102(2):493-6. PubMed ID: 1732120
[TBL] [Abstract][Full Text] [Related]
15. Triple antimicrobial therapy and acid suppression in dogs with chronic vomiting and gastric Helicobacter spp.
Leib MS; Duncan RB; Ward DL
J Vet Intern Med; 2007; 21(6):1185-92. PubMed ID: 18196724
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Helicobacter pylori infection: summary of a meeting at the Fourth United European Gastroenterology Week, September 20, 1995.
Mégraud F; Malfertheiner P
Helicobacter; 1996 Jun; 1(2):118-21. PubMed ID: 9398889
[No Abstract] [Full Text] [Related]
17. Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial.
Lee JY; Kim N; Park KS; Kim HJ; Park SM; Baik GH; Shim KN; Oh JH; Choi SC; Kim SE; Kim WH; Park SY; Kim GH; Lee BE; Jo Y; Hong SJ
BMC Gastroenterol; 2016 Jul; 16(1):79. PubMed ID: 27460100
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic and histologic resolution of gastric pseudolymphoma (reactive lymphoid hyperplasia) following treatment with bismuth and oral antibiotics.
Weston AP; Campbell DR; McGregor DH; Cherian R
Dig Dis Sci; 1994 Dec; 39(12):2567-74. PubMed ID: 7995181
[TBL] [Abstract][Full Text] [Related]
19. Short report: a non-metronidazole triple therapy for eradication of Helicobacter pylori infection--tetracycline, amoxicillin, bismuth.
Graham DY; Lew GM; Ramirez FC; Genta RM; Klein PD; Malaty HM
Aliment Pharmacol Ther; 1993 Feb; 7(1):111-3. PubMed ID: 8439632
[TBL] [Abstract][Full Text] [Related]
20. Long-term Helicobacter pylori recurrence after successful eradication with triple therapy.
Cutler AF; Schubert TT
Am J Gastroenterol; 1993 Sep; 88(9):1359-61. PubMed ID: 8362830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]